/

Investors / Cancer Research Horizons / Compare with Oxford Science Enterprises

Cancer Research Horizons vs Oxford Science Enterprises

Cancer Research Horizons lists 6 portfolio companies and has joined 3 funding rounds; Oxford Science Enterprises lists 75 companies and has joined 20 rounds. Cancer Research Horizons comes in most often at Series A (67% of its entries), Oxford Science Enterprises comes in most often at Seed (35% of its entries). 1 company is on both portfolios, among them Alethio Therapeutics.

6Portfolio companies75
3Funding rounds joined20
0Rounds led6
2Rounds, last 12 months19
$20M to $100MTypical round it comes in at$20M to $100M
0%Sites no longer answering0%
Show as a table
Cancer Research Horizons and Oxford Science Enterprises, head to head
Cancer Research HorizonsOxford Science Enterprises
Portfolio companies675
Funding rounds joined320
Rounds led06
Rounds, last 12 months219
Typical round it comes in at$20M to $100M$20M to $100M
Sites no longer answering0%0%

Where they come in

share of entries by stage
Pre-seed0%0%
Seed33%35%
Series A67%35%
Series B0%5%
Growth0%25%

Cancer Research HorizonsOxford Science Enterprises

Show as a table
Entry stages of Cancer Research Horizons and Oxford Science Enterprises, share of entries
Cancer Research HorizonsOxford Science Enterprises
Pre-seed0%0%
Seed33%35%
Series A67%35%
Series B0%5%
Growth0%25%

Themes

share of checked companies
Healthcare & Biotech100%38%
AI & Machine Learning0%22%
Industrial & Manufacturing0%14%
Education0%10%
Cybersecurity0%5%
Enterprise Software0%3%

Cancer Research HorizonsOxford Science Enterprises

Show as a table
Themes of Cancer Research Horizons and Oxford Science Enterprises, share of checked companies
Cancer Research HorizonsOxford Science Enterprises
Healthcare & Biotech100%38%
AI & Machine Learning0%22%
Industrial & Manufacturing0%14%
Education0%10%
Cybersecurity0%5%
Enterprise Software0%3%

Companies both back

1

Shared companies are those both firms' own portfolio pages list, each checked against the company's site. The same comparison through the API is POST /v1/overlap, for up to 20 firms. How the data is graded

Free account · no card

Compare Cancer Research Horizons and Oxford Science Enterprises as data

Pull both portfolios and every co-investor through one API key or MCP, and lay up to 20 firms side by side with POST /v1/overlap. A free account adds Ask AI searches and alerts when either firm adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/cancerresearchhorizons.com/portfolio

# also
GET /v1/firms/oxfordscienceenterprises.com/portfolio
GET /v1/firms/cancerresearchhorizons.com/coinvestors
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing